Cue Biopharma Stock Forecast - Accumulation Distribution
| CUE Stock | USD 0.38 0.02 5.56% |
Cue Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Cue Biopharma stock prices and determine the direction of Cue Biopharma's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Cue Biopharma's historical fundamentals, such as revenue growth or operating cash flow patterns.
At the present time the rsi of Cue Biopharma's share price is below 20 suggesting that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
EPS Estimate Next Quarter (0.1) | EPS Estimate Current Year (0.41) | EPS Estimate Next Year (0.48) | Wall Street Target Price 5 | EPS Estimate Current Quarter (0.09) |
Using Cue Biopharma hype-based prediction, you can estimate the value of Cue Biopharma from the perspective of Cue Biopharma response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Cue Biopharma using Cue Biopharma's stock options and short interest. It helps to benchmark the overall future attitude of investors towards Cue using crowd psychology based on the activity and movement of Cue Biopharma's stock price.
Cue Biopharma Short Interest
A significant increase or decrease in Cue Biopharma's short interest from the previous month could be a good indicator of investor sentiment towards Cue. Short interest can provide insight into the potential direction of Cue Biopharma stock and how bullish or bearish investors feel about the market overall.
200 Day MA 0.6751 | Short Percent 0.0158 | Short Ratio 1.16 | Shares Short Prior Month 368.8 K | 50 Day MA 0.4466 |
Cue Biopharma Hype to Price Pattern
Investor biases related to Cue Biopharma's public news can be used to forecast risks associated with an investment in Cue. The trend in average sentiment can be used to explain how an investor holding Cue can time the market purely based on public headlines and social activities around Cue Biopharma. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Cue Biopharma Implied Volatility | 1.19 |
Cue Biopharma's implied volatility exposes the market's sentiment of Cue Biopharma stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Cue Biopharma's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Cue Biopharma stock will not fluctuate a lot when Cue Biopharma's options are near their expiration.
Cue Biopharma after-hype prediction price | USD 0.47 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Cue Biopharma to cross-verify your projections. Open Interest Against 2026-04-17 Cue Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast Cue Biopharma's spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Cue Biopharma's options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Cue Biopharma stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Cue Biopharma's open interest, investors have to compare it to Cue Biopharma's spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Cue Biopharma is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Cue. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Cue Biopharma Additional Predictive Modules
Most predictive techniques to examine Cue price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Cue using various technical indicators. When you analyze Cue charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Previous Accumulation Distribution | Accumulation Distribution | Trend |
| 101939.0 | 0.1 |
| Check Cue Biopharma Volatility | Backtest Cue Biopharma | Information Ratio |
Cue Biopharma Trading Date Momentum
| On January 25 2026 Cue Biopharma was traded for 0.38 at the closing time. Highest Cue Biopharma's price during the trading hours was 0.39 and the lowest price during the day was 0.35 . There was no trading activity during the period 0.0. Lack of trading volume on the 25th of January did not affect price variability. The overall trading delta to current price is 0.00% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
| Compare Cue Biopharma to competition |
Other Forecasting Options for Cue Biopharma
For every potential investor in Cue, whether a beginner or expert, Cue Biopharma's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Cue Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Cue. Basic forecasting techniques help filter out the noise by identifying Cue Biopharma's price trends.Cue Biopharma Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Cue Biopharma stock to make a market-neutral strategy. Peer analysis of Cue Biopharma could also be used in its relative valuation, which is a method of valuing Cue Biopharma by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Cue Biopharma Market Strength Events
Market strength indicators help investors to evaluate how Cue Biopharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Cue Biopharma shares will generate the highest return on investment. By undertsting and applying Cue Biopharma stock market strength indicators, traders can identify Cue Biopharma entry and exit signals to maximize returns.
Cue Biopharma Risk Indicators
The analysis of Cue Biopharma's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Cue Biopharma's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting cue stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 5.36 | |||
| Standard Deviation | 8.24 | |||
| Variance | 67.86 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Cue Biopharma
The number of cover stories for Cue Biopharma depends on current market conditions and Cue Biopharma's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Cue Biopharma is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Cue Biopharma's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Cue Biopharma Short Properties
Cue Biopharma's future price predictability will typically decrease when Cue Biopharma's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Cue Biopharma often depends not only on the future outlook of the potential Cue Biopharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Cue Biopharma's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 56.3 M | |
| Cash And Short Term Investments | 23.4 M |
Check out Historical Fundamental Analysis of Cue Biopharma to cross-verify your projections. For information on how to trade Cue Stock refer to our How to Trade Cue Stock guide.You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cue Biopharma. If investors know Cue will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cue Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.41) | Revenue Per Share | Quarterly Revenue Growth (0.36) | Return On Assets | Return On Equity |
The market value of Cue Biopharma is measured differently than its book value, which is the value of Cue that is recorded on the company's balance sheet. Investors also form their own opinion of Cue Biopharma's value that differs from its market value or its book value, called intrinsic value, which is Cue Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cue Biopharma's market value can be influenced by many factors that don't directly affect Cue Biopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cue Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cue Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cue Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.